Delivery Order SPE2DB20D3111-SPE2DB25FA9QK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Irbesartan 150 mg tablets in quantities of 90 units, with a contract ceiling value of $2,260.39. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $1,357.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Irbesartan 75 mg tablets in quantities of 90 units. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,776.40 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Irbesartan 150 mg tablets (90-count packaging). This competitive award utilizes firm fixed pricing with an ultimate completion date of September 26, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,035.92 to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (90-count) on September 16, 2025, with completion anticipated by September 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of a generic antihypertensive medication to support federal healthcare operations. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a $5,160.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Irbesartan 150 mg on August 11, 2025, with completion due by August 12, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Irbesartan 75 mg tablets in a quantity of 90 units, with a ceiling value of $5,990.86. This contract, classified as a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $26,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 150mg tablets of Irbesartan, totaling 90 tablets, to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late August 2023. As the prime contractor, Amerisourcebergen Drug Corporation will...
- The Defense Logistics Agency awarded a $3,330 delivery order to Amerisourcebergen Drug Corporation for Irbesartan 75 mg tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 90 tablets of the hypertension medication to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 defense contractor, Amerisourcebergen frequently provides pharmaceuticals and medical supplies to the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets. The contract has a period of performance through November 12, 2024 and does not include any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $25,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg irbesartan tablets. Under this order, Amerisourcebergen will deliver 90 count bottles of the hypertension medication to a location in Conshohocken, Pennsylvania by June 26, 2023 in support of Department of Defense pharmacuetical needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders for established Federal Supply...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9QKDelivery Order
The Defense Logistics Agency awarded a $1,733.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Irbesartan 150 mg tablets (90-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, fulfills the delivery requirements at its corporate office location. AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for federal military and veteran healthcare systems, supplying a comprehensive range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. As a prime vendor under the DLA Troop Support Medical contract, the company competitively delivers pharmaceutical products to support Defense Health Agency operations and other government healthcare systems. This specific order for Irbesartan, a common antihypertensive medication, exemplifies the company's role in providing routine pharmaceutical inventory to federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/22/25 |